ARS Pharmaceuticals, Inc.

By person

25 insiders · 261 transactions

Insider

Role

Bought

Sold

Net

Holding

Worth

Change

RA CAPITAL MANAGEMENT, L.P. entity

Director

$44.72M (6)

—

+$44.72M

9,958,073

$99.58M

—

Lowenthal Richard E

PRESIDENT AND CEO

—

$23.82M (73) scheduled

−$23.82M

5,523,683

$55.24M

—

Flynn James E

10% owner

—

$23.81M (10)

−$23.81M

4,887,254

$48.87M

−21.1%

Tanimoto Sarina

CHIEF MEDICAL OFFICER

—

$23.80M (74) scheduled

−$23.80M

4,680,959

$46.81M

—

ORBIMED ADVISORS LLC entity

Director

$28.10M (3)

$12.59M (5)

+$15.51M

8,740,888

$87.41M

+782.0%

Thompson Peter A.

Director

$28.10M (3)

$12.59M (5)

+$15.51M

8,740,888

$87.41M

+782.0%

Shawver Laura

Director

—

$8.63M (23) scheduled

−$8.63M

210,346

$2.10M

+163.3%

Chakma Justin

Chief Business Officer

—

$8.56M (13) scheduled

−$8.56M

$0.00

—

Schroeder Thilo

Director

$5.00M (1)

—

+$5.00M

1,910,029

$19.10M

—

ROOT JONATHAN D

Director

$2.04M (3)

—

+$2.04M

2,269,417

$22.69M

+4.5%

Dorsey Brian

Chief Operating Officer

—

$1.82M (5) scheduled

−$1.82M

10,789

$107.89K

0.0%

SAUNDERS BRENT L

Director

—

$1.71M (1) scheduled

−$1.71M

$0.00

—

Karas Eric

Chief Commercial Officer

—

$1.31M (8) scheduled

−$1.31M

12,176

$121.76K

0.0%

Scott Kathleen D.

Chief Financial Officer

$51.51K (1)

$1.29M (4) scheduled

−$1.24M

18,292

$182.92K

+82.2%

Fitzpatrick Alexander A

Chief Legal Officer

$319.95K (2)

$1.49M (2) scheduled

−$1.17M

90,910

$909.10K

+728.3%

Presidio Management Group XII, L.L.C. entity

10% owner

$1,000.00K (1)

—

+$1,000.00K

2,221,798

$22.22M

—

Piazza Jonathan

Chief Financial Officer

$249.98K (1)

—

+$249.98K

69,225

$692.25K

+2,809%

CAPPS VICKIE L

Director

$199.98K (1)

—

+$199.98K

61,576

$615.76K

+18.3%

Hawkinson Russ

Sr. Vice President of Finance

$5.00K (1)

—

+$5.00K

37,251

$372.51K

+3,062%

Shah Pratik

Director

—

4,474,554

$44.75M

—

Dadoo Rajeev

Director

—

3,009,677

$30.10M

—

Alexandria Venture Investments, LLC entity

10% owner

—

699,412

$6.99M

—

Kelly Michael

Director

—

83,225

$832.25K

—

Odegard Valerie

President and CSO

—

61,639

$616.39K

—

Hunder Naomi

Chief Medical Officer

—

54,427

$544.27K

—

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Individual transactions

Insider

Date

Role

Action

Price

Amount

RA CAPITAL MANAGEMENT, L.P.

27 Mar 2024

Director

Buy indirect

505,954

$9.79

$4.95M

RA CAPITAL MANAGEMENT, L.P.

26 Mar 2024

Director

Buy indirect

457,745

$9.55

$4.37M

RA CAPITAL MANAGEMENT, L.P.

25 Mar 2024

Director

Buy indirect

437,600

$9.06

$3.96M

Fitzpatrick Alexander A

29 Sep 2023

Chief Legal Officer

Buy

46,258

$3.78

$174.99K

Fitzpatrick Alexander A

28 Sep 2023

Chief Legal Officer

Buy

40,000

$3.62

$144.96K

RA CAPITAL MANAGEMENT, L.P.

21 Sep 2023

Director

Buy indirect

191,309

$3.83

$732.71K

RA CAPITAL MANAGEMENT, L.P.

21 Sep 2023

Director

Buy indirect

2,508,691

$2.97

$7.45M

Thompson Peter A.

29 Aug 2023

Director

Buy indirect

500,000

$6.20

$3.10M

ORBIMED ADVISORS LLC

29 Aug 2023

Director

Buy indirect

500,000

$6.20

$3.10M

RA CAPITAL MANAGEMENT, L.P.

29 Aug 2023

Director

Buy indirect

3,750,000

$6.20

$23.25M

Scott Kathleen D.

29 Nov 2022

Chief Financial Officer

Buy indirect

8,250

$6.24

$51.51K

ROOT JONATHAN D

15 Nov 2021

Director

Buy indirect

2,014

$8.85

$17.82K

Showing 250 of 261 transactions. The figures above use every one of them.

ARS Pharmaceuticals, Inc.

By person

Individual transactions

What was left out